Evidence mapPaperPMID 41201300Full record

ArticleMultidisciplinary respiratory medicine2025

EGOI-PCOS survey on the prevalence of respiratory disorders associated with polycystic ovary syndrome.

Mario Montanino Oliva, Maurizio Nordio, Orietta Picconi, Giuseppina Porcaro

Abstract read
In one paragraph

Article in Multidisciplinary respiratory medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mario Montanino OlivaDepartment of Obstetrics and Gynecology, Santo Spirito Hospital, Rome, Italy; The Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), Rome, Italy.
Maurizio NordioDepartment of Experimental Medicine, Sapienza University, Rome, Italy; The Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), Rome, Italy.
Orietta PicconiNational HIV/AIDS Research Center (CNAIDS), Istituto Superiore di Sanità, Rome, Italy.
Giuseppina PorcaroClinica Sotherga, Milan, Italy; The Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPolycystic Ovary Syndrome (PCOS) is a multifaceted disorder that has also recently been associated with chronic respiratory diseases (CRDs). While several studies have highlighted that pulmonary health is frequently altered in women with PCOS and vice versa, no mechanistic investigation has elucidated an overlapped etiology, so far. Thus, in the present survey we explored the frequency of respiratory issues in a population of PCOS patients, and the medical characteristics that possibly link the two diseases.

resultsA total of 353 women participated in the survey. CRDs affected 27.4% of the surveyed PCOS patients, with asthma representing the most prevalent respiratory problem in 61.5% of cases. In 59.3% of women, respiratory and PCOS onset appaired at the same age and in 68% of cases first symptoms appeared in adolescence.

conclusionsWhile several authors have linked respiratory issues and menstrual disturbances, there are no available surveys that investigate the frequency of CRDs in PCOS patients. Despite their qualitative nature, our results sustain previous indications on a possible link between CRDs and PCOS. In future, appropriate studies may elucidate possible etiological mechanisms joining respiratory health to PCOS.

Identifiers

PMID41201300
PMCPMC12674184

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.